Not only that, but the analysis seems to be based on rather small sample studies, all based in Iran, the worlds largest saffron exporting country.

At least they state this caveat themselves "Larger clinical trials, conducted by research teams outside of Iran, with long-term follow-ups are needed before firm conclusions can be made regarding saffron's efficacy and safety for treating depressive symptoms."

This is not news worthy at all.